Clinical Trial

Prevent Cancer- Greenville

Study acronym: CCPW
Recruiting
View on ClinicalTrials.gov →
Summary
Prevent Cancer-Greenville was created to provide individuals with the opportunity to have their risk of developing cancer studied. Some individuals may be at a higher risk due to their personal lifestyle, family history and/or exposures. If subjects are found to be at high risk for developing a disease, they will be sent to a healthcare provider for further care.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-06-23; most recent amendment 2026-02-11.
Trial Details
NCT Number NCT04947098
Lead Sponsor Prisma Health-Upstate
Conditions Cancer, High-Risk Cancer
Enrollment 1,000 participants
Start Date 2018-11-08
Primary Completion 2028-11-08 (estimated)
Study Completion 2029-11-08 (estimated)
Updated on ClinicalTrials.gov 2026-02-17